United Kingdom· GB-APID-24653111000001104
Saccharomyces Boulardii 250mg capsules
A saccharomyces boulardii product containing saccharomyces boulardii, registered in United Kingdom by Special Order. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Saccharomyces boulardii is registered in 10 of 19 countries.
Countries holding a registration under ATC A07FA02 (saccharomyces boulardii), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Saccharomyces boulardii · ATC A07FA02
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of saccharomyces boulardii costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Saccharomyces boulardii · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.16
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Saccharomyces boulardii
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- A07FA02
- ATC class
- Saccharomyces boulardii
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saccharomyces boulardii in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAntediar 250 mgWill Pharma
- CzechiaENTEROLPetsiavas S.A., Kifisia
- SpainULTRA-LEVURA 250 MG CAPSULAS DURASPetsiavas S.A. Industrial And Commercial Enterprises
- FinlandPrecosaParanova Oy
- NorwayCodex 5 miliardiBiocodex
- PolandLakcid ENTEROZakłady Farmaceutyczne POLPHARMA S.A.
- GermanyBoulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, LyophilisiertPharma Zentrale Gmbh
- United StatesA-34DNA Labs, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Yomogi
- Belgium · Sacchiflora
- Cyprus · Bioflor
- Germany · Boulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, Lyophilisiert, Ceritract
- Italy · Codex, Preparazione H
- Portugal · Prolif
- Sweden · Precosa
- Slovakia · Yomogi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/628ff933-275c-4188-a0e2-8079eb3ce352 GET /v1/drugs/628ff933-275c-4188-a0e2-8079eb3ce352?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "24653111000001104",
"desc": "Saccharomyces Boulardii 250mg capsules (Special Order)",
"form": "Oral capsule",
"vpid": "22375111000001100",
"source": "dmd",
"vtm_id": null,
"strength": null,
"substance": null,
"ingredient": "Saccharomyces boulardii",
"supplier_code": "8286711000001104"
}See everything about saccharomyces boulardii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.